US pharmaceutical companies ran drug trials with Chinese military for more than a decade, House committee reveals
“These collaborative research activities raise serious concerns that critical Intellectual Property is at risk of being transferred to the [Chinese military] or being co-opted under the People’s Republic of China’s National Security Law,” said Chairman John Moolenaar (R-Mich.), Ranking Member Raja Krishnamoorthi (D-Ill.), Rep. Neal Dunn (R-Fla.) and Rep. Anna Eshoo (D-Calif.).